OOIR: Observatory of International Research

Papers

(The H4-Index of Trends in Molecular Medicine is 44. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Advisory Board and Contents	218
Subscription and Copyright Information	213
Subscription and Copyright Information	188
Advisory Board and Contents	187
Stories in Molecular Medicine December 2021	184
Advisory Board and Contents	152
Subscription and Copyright Information	144
Advisory Board and Contents	133
Subscription and Copyright Information	122
Subscription and Copyright Information	118
Pre-eclampsia: Challenges for Nanomedicine Development in Pregnancy	113
Neutrophils and extracellular traps in crystal-associated diseases	108
Fc-optimized checkpoint antibodies for cancer immunotherapy	105
m6A and beyond: RNA modifications shaping angiogenesis	105
Bursts of brain erosion: seizures and age-dependent neurological vulnerability	97
Opportunities and challenges for biomarker discovery using electronic health record data	97
Beneath the radar: immune-evasive cell sources for stroke therapy	94
Pushing the boundaries of brain organoids to study Alzheimer’s disease	94
Cellular senescence in neuroinflammatory disease: new therapies for old cells?	90
Medical imaging of pulmonary disease in SARS-CoV-2-exposed non-human primates	88
d-Amino acids: new clinical pathways for brain diseases	82
Hyperemesis gravidarum theories dispelled by recent research: a paradigm change for better care and outcomes	77
Consideration of the importance of measuring thermal discomfort in biomedical research	76
Advancements in intensive eating disorder treatments: the benefit of CBT-E and integrated care models	75
Subscription and Copyright Information	73

Stories in Molecular Medicine November 2021	72
Insights from HIV-1 vaccine and passive immunization efficacy trials	67
Systemically administered alcadein peptide p3-Alcβ neutralizes brain Alzheimer’s Aβ oligomers	67
Brain-specific regulatory T cell expansion limits cognitive decline	66
Hormesis as an adaptive response to infection	63
Engineering cytokines for tumor-targeting and selective T cell activation	63
iPSCs and DRGs: stepping stones to new pain therapies	63
Acquired resistance to immunotherapy in solid tumors	62
Erythropoietic protoporphyrias: updates and advances	61
Cell-free circulating tumor DNA profiling in cancer management	60
Microbes and mood: innovative biomarker approaches in depression	59
Skeletal muscle mitochondrial network dynamics in metabolic disorders and aging	50
Advisory Board and Contents	50
HDAC inhibitors as pharmacological treatment for Duchenne muscular dystrophy: a discovery journey from bench to patients	50
RNA immunotherapy: revolutionizing cancer and autoimmune disease treatments	49
Molecular mechanisms in the pathogenesis of dengue infections	49
Keratinocytes: new perspectives in inflammatory skin diseases	47
Emerging roles of cyclin-dependent kinase 7 in health and diseases	47
Amyloid and collagen templates in aortic valve calcification	44
Manipulating the gut and tumor microbiota for immune checkpoint inhibitor therapy: from dream to reality	44